-
Je něco špatně v tomto záznamu ?
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
D. Chakraborty, B. Šumová, T. Mallano, CW. Chen, A. Distler, C. Bergmann, I. Ludolph, RE. Horch, K. Gelse, A. Ramming, O. Distler, G. Schett, L. Šenolt, JHW. Distler,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2015
Free Medical Journals
od 2010
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2010-01-01 do 2017-12-31
Open Access Digital Library
od 2015-01-01
Open Access Digital Library
od 2015-01-01
Medline Complete (EBSCOhost)
od 2012-11-01
Health & Medicine (ProQuest)
od 2010-01-01 do 2017-12-31
ROAD: Directory of Open Access Scholarly Resources
od 2010
Springer Nature OA/Free Journals
od 2010-12-01
Springer Nature - nature.com Journals - Fully Open Access
od 2010-12-01
- MeSH
- aktivace enzymů MeSH
- benzensulfonáty chemie MeSH
- biopsie MeSH
- bleomycin chemie MeSH
- dospělí MeSH
- fibroblasty metabolismus MeSH
- fibróza metabolismus MeSH
- fosforylace MeSH
- kolagen chemie MeSH
- konfokální mikroskopie MeSH
- kůže metabolismus MeSH
- kyseliny aminosalicylové chemie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- myši MeSH
- receptory transformujícího růstového faktoru beta metabolismus MeSH
- senioři MeSH
- signální transdukce fyziologie MeSH
- systémová sklerodermie metabolismus MeSH
- transformující růstový faktor beta metabolismus MeSH
- transkripční faktor STAT3 metabolismus MeSH
- zánět MeSH
- zvířata MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- myši MeSH
- senioři MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Signal transducer and activator of transcription 3 (STAT3) is phosphorylated by various kinases, several of which have been implicated in aberrant fibroblast activation in fibrotic diseases including systemic sclerosis (SSc). Here we show that profibrotic signals converge on STAT3 and that STAT3 may be an important molecular checkpoint for tissue fibrosis. STAT3 signaling is hyperactivated in SSc in a TGFβ-dependent manner. Expression profiling and functional studies in vitro and in vivo demonstrate that STAT3 activation is mediated by the combined action of JAK, SRC, c-ABL, and JNK kinases. STAT3-deficient fibroblasts are less sensitive to the pro-fibrotic effects of TGFβ. Fibroblast-specific knockout of STAT3, or its pharmacological inhibition, ameliorate skin fibrosis in experimental mouse models. STAT3 thus integrates several profibrotic signals and might be a core mediator of fibrosis. Considering that several STAT3 inhibitors are currently tested in clinical trials, STAT3 might be a candidate for molecular targeted therapies of SSc.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033631
- 003
- CZ-PrNML
- 005
- 20181009110327.0
- 007
- ta
- 008
- 181008s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41467-017-01236-6 $2 doi
- 035 __
- $a (PubMed)29066712
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Chakraborty, Debomita $u Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, 91054, Germany.
- 245 10
- $a Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis / $c D. Chakraborty, B. Šumová, T. Mallano, CW. Chen, A. Distler, C. Bergmann, I. Ludolph, RE. Horch, K. Gelse, A. Ramming, O. Distler, G. Schett, L. Šenolt, JHW. Distler,
- 520 9_
- $a Signal transducer and activator of transcription 3 (STAT3) is phosphorylated by various kinases, several of which have been implicated in aberrant fibroblast activation in fibrotic diseases including systemic sclerosis (SSc). Here we show that profibrotic signals converge on STAT3 and that STAT3 may be an important molecular checkpoint for tissue fibrosis. STAT3 signaling is hyperactivated in SSc in a TGFβ-dependent manner. Expression profiling and functional studies in vitro and in vivo demonstrate that STAT3 activation is mediated by the combined action of JAK, SRC, c-ABL, and JNK kinases. STAT3-deficient fibroblasts are less sensitive to the pro-fibrotic effects of TGFβ. Fibroblast-specific knockout of STAT3, or its pharmacological inhibition, ameliorate skin fibrosis in experimental mouse models. STAT3 thus integrates several profibrotic signals and might be a core mediator of fibrosis. Considering that several STAT3 inhibitors are currently tested in clinical trials, STAT3 might be a candidate for molecular targeted therapies of SSc.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kyseliny aminosalicylové $x chemie $7 D000636
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a benzensulfonáty $x chemie $7 D001557
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a bleomycin $x chemie $7 D001761
- 650 _2
- $a kolagen $x chemie $7 D003094
- 650 _2
- $a aktivace enzymů $7 D004789
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibroblasty $x metabolismus $7 D005347
- 650 _2
- $a fibróza $x metabolismus $7 D005355
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $7 D007249
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a konfokální mikroskopie $7 D018613
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a receptory transformujícího růstového faktoru beta $x metabolismus $7 D018125
- 650 _2
- $a transkripční faktor STAT3 $x metabolismus $7 D050796
- 650 _2
- $a systémová sklerodermie $x metabolismus $7 D012595
- 650 _2
- $a signální transdukce $x fyziologie $7 D015398
- 650 _2
- $a kůže $x metabolismus $7 D012867
- 650 _2
- $a transformující růstový faktor beta $x metabolismus $7 D016212
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Šumová, Barbora $u Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, 91054, Germany. Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, 120 00, Czech Republic.
- 700 1_
- $a Mallano, Tatjana $u Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, 91054, Germany.
- 700 1_
- $a Chen, Chih-Wei $u Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, 91054, Germany.
- 700 1_
- $a Distler, Alfiya $u Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, 91054, Germany.
- 700 1_
- $a Bergmann, Christina $u Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, 91054, Germany.
- 700 1_
- $a Ludolph, Ingo $u Department of Plastic and Hand Surgery and Laboratory for Tissue Engineering and Regenerative Medicine, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, 91054, Germany.
- 700 1_
- $a Horch, Raymund E $u Department of Plastic and Hand Surgery and Laboratory for Tissue Engineering and Regenerative Medicine, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, 91054, Germany.
- 700 1_
- $a Gelse, Kolja $u Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, 91054, Germany.
- 700 1_
- $a Ramming, Andreas $u Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, 91054, Germany.
- 700 1_
- $a Distler, Oliver $u Center of Experimental Rheumatology and Zurich Center of Integrative Human Physiology, University Hospital Zurich, Zurich, 8091, Switzerland.
- 700 1_
- $a Schett, Georg $u Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, 91054, Germany.
- 700 1_
- $a Šenolt, Ladislav $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, 120 00, Czech Republic.
- 700 1_
- $a Distler, Jörg H W $u Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, 91054, Germany. joerg.distler@uk-erlangen.de.
- 773 0_
- $w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 8, č. 1 (2017), s. 1130
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29066712 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181009110815 $b ABA008
- 999 __
- $a ok $b bmc $g 1340232 $s 1030625
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 8 $c 1 $d 1130 $e 20171024 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
- LZP __
- $a Pubmed-20181008